Exelixis (EXEL) News Today $37.90 -0.61 (-1.58%) Closing price 04:00 PM EasternExtended Trading$37.92 +0.02 (+0.04%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EXEL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Exelixis’s Promising Study on XB371: A New Hope for Solid Tumors4 hours ago | tipranks.comCaisse DE Depot ET Placement DU Quebec Has $98.13 Million Stock Position in Exelixis, Inc. $EXELAugust 28 at 7:18 AM | marketbeat.comExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in SeptemberAugust 27 at 4:05 PM | businesswire.comExelixis and Novartis: Key Updates from the Pan Tumor Rollover StudyAugust 27 at 12:51 PM | tipranks.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 27 at 10:00 AM | prnewswire.comNorthern Trust Corp Trims Holdings in Exelixis, Inc. $EXELAugust 27 at 4:02 AM | marketbeat.comAmerican Century Companies Inc. Grows Stake in Exelixis, Inc. $EXELAugust 26 at 3:50 AM | marketbeat.comExelixis: RCC Stronghold, NET Launch, And A CRC Readout That MattersAugust 25 at 6:10 PM | seekingalpha.comExelixis’s Promising Study on Renal Cell Carcinoma: A Potential Game Changer?August 25 at 1:06 PM | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 25 at 12:14 PM | globenewswire.comSystematic Financial Management LP Sells 31,115 Shares of Exelixis, Inc. $EXELAugust 25 at 8:58 AM | marketbeat.comCapital Fund Management S.A. Lowers Stock Position in Exelixis, Inc. $EXELAugust 24, 2025 | marketbeat.comExelixis, Inc. $EXEL Shares Sold by Erste Asset Management GmbHAugust 24, 2025 | marketbeat.comZacks Research Has Bearish Forecast for Exelixis Q4 EarningsAugust 23, 2025 | marketbeat.comKaufman Rossin Wealth LLC Buys Shares of 7,286 Exelixis, Inc. $EXELAugust 23, 2025 | marketbeat.comCandriam S.C.A. Cuts Stock Holdings in Exelixis, Inc. $EXELAugust 23, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Reduces Stock Holdings in Exelixis, Inc. $EXELAugust 23, 2025 | marketbeat.comExelixis, Inc. $EXEL Shares Sold by Dimensional Fund Advisors LPAugust 23, 2025 | marketbeat.comEquities Analysts Set Expectations for Exelixis Q4 EarningsAugust 23, 2025 | americanbankingnews.comExelixis Earns Relative Strength Rating UpgradeAugust 22, 2025 | msn.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 22, 2025 | prnewswire.comIs Exelixis Still Attractive After Recent 13% Pullback and Strong Cash Flow Growth?August 22, 2025 | finance.yahoo.comZacks Research Has Bullish Outlook for Exelixis Q3 EarningsAugust 22, 2025 | marketbeat.comBI Asset Management Fondsmaeglerselskab A S Has $7.86 Million Stock Position in Exelixis, Inc. $EXELAugust 22, 2025 | marketbeat.comDeutsche Bank AG Has $2.80 Million Position in Exelixis, Inc. $EXELAugust 22, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 21, 2025 | globenewswire.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Grows Stake in Exelixis, Inc. $EXELAugust 21, 2025 | marketbeat.comAlgert Global LLC Decreases Stake in Exelixis, Inc. $EXELAugust 21, 2025 | marketbeat.comZacks Research Estimates Exelixis' Q3 Earnings (NASDAQ:EXEL)August 21, 2025 | americanbankingnews.comExelixis, Inc. $EXEL is Fuller & Thaler Asset Management Inc.'s 9th Largest PositionAugust 20, 2025 | marketbeat.comCambiar Investors LLC Sells 43,008 Shares of Exelixis, Inc. $EXELAugust 20, 2025 | marketbeat.comBrandywine Global Investment Management LLC Invests $5.13 Million in Exelixis, Inc. $EXELAugust 20, 2025 | marketbeat.comExelixis’s Promising Study on Renal Cell Carcinoma: Key Updates for InvestorsAugust 19, 2025 | msn.comExelixis, Inc. (NASDAQ:EXEL) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 19, 2025 | marketbeat.comRussell Investments Group Ltd. Has $22.47 Million Position in Exelixis, Inc. (NASDAQ:EXEL)August 18, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 18, 2025 | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 17, 2025 | globenewswire.com73,690 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Element Capital Management LLCAugust 17, 2025 | marketbeat.comH.C. Wainwright Maintains Buy on Exelixis (EXEL) Despite STELLAR-305 Phase 3 SetbackAugust 17, 2025 | insidermonkey.comH.C. Wainwright Maintains Buy on Exelixis (EXEL) Despite STELLAR-305 Phase 3 SetbackAugust 17, 2025 | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. ...August 16, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 16, 2025 | prnewswire.comExelixis, Inc. (NASDAQ:EXEL) Shares Acquired by Prudential PLCAugust 15, 2025 | marketbeat.comInvesco Ltd. Buys 1,596,948 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 15, 2025 | marketbeat.comCitigroup Inc. Purchases 152,240 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 15, 2025 | marketbeat.comSwiss National Bank Sells 7,000 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 15, 2025 | marketbeat.comNuveen LLC Invests $123.31 Million in Exelixis, Inc. (NASDAQ:EXEL)August 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXELAugust 13, 2025 | globenewswire.comCharles Schwab Investment Management Inc. Buys 69,054 Shares of Exelixis, Inc. (NASDAQ:EXEL)August 13, 2025 | marketbeat.comExelixis, Inc. (NASDAQ:EXEL) Holdings Trimmed by Vanguard Group Inc.August 13, 2025 | marketbeat.com Get Exelixis News Delivered to You Automatically Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. EXEL Media Mentions By Week EXEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXEL News Sentiment▼0.900.99▲Average Medical News Sentiment EXEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXEL Articles This Week▼2722▲EXEL Articles Average Week Get the Latest News and Ratings for EXEL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Exelixis and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biogen News Incyte News United Therapeutics News Neurocrine Biosciences News BioMarin Pharmaceutical News Exact Sciences News Madrigal Pharmaceuticals News Halozyme Therapeutics News Repligen News Ionis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXEL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access